Sequencing-Based Diagnostics Critical to Fighting Against Infectious Disease
November 9 2022
Listen to our Co-founder & CEO, Jong Lee, speak with ICT Magazine about the critical role of Sequencing-Based Diagnostics in the fight against infectious disease.
Read More
Day Zero Diagnostics Appoints Gail Marcus to its Board
November 9 2022
Day Zero Diagnostics appoints Gail Marcus to its Board of Directors as an independent director.
Read More
Day Zero Diagnostics raises $8.2M from CARB-X
October 24 2022
Day Zero Diagnostics receives an $8.2 million award in optional stage funding from CARB-X.
Read More
Day Zero receives $8.2M to speed development of infectious disease diagnostic
October 21 2022
Day Zero receives $8.2M from CARB-X to speed development of infectious disease diagnostics.
Read More
Day Zero Diagnostics secures additional $8.2M from CARB-X
October 20 2022
Additional CARB-X funding supports the transition into product development of the firm's whole-genome sequencing and machine learning-based approach to antimicrobial resistance profiling.
Read More
Day Zero Diagnostics at EADA 2021: A better way to diagnose and treat sepsis is on the horizon
January 5 2022
Learn how we are predicting antimicrobial susceptibility directly from blood using whole-genome sequencing with Day Zero Diagnostic's Scientific Co-founder, Melis Anahtar, MD, Phd.
Read More